Amber Pepper is a Rheumatology/Immunology physician affiliated with University of South Florida. OpenAlex indexes 39 publications with 837 citations (h-index 15).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
13801 Bruce B Downs Blvd Ste 502
Tampa, FL 336133923
Telephone
813-971-9743Provider last certified this registry record 26 Mar 2025.
Industry payments
35 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Novartis Pharmaceuticals CorporationProgram year202512 payments
- AstraZeneca Pharmaceuticals LPProgram year202511 payments
- Regeneron Healthcare Solutions, Inc.Program year20254 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Respiratory
94.7%Corticosteroid51.9%Fluticasone Propionate40%Trelegy Ellipta30%Symbicort16%Breo Ellipta14%Part D<11 patientsLeukotriene Receptor Antagonist14%Montelukast Sodium100%Part D≥12 patients+ 3 more classes in this area
Metabolism & gastrointestinal
5.3%Corticosteroid5.3%Prednisone100%Part D≥13 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- PrecISE—a biomarker-stratified adaptive trial of 5 interventions in severe asthma: Final protocol and the baseline cohort
Journal of Allergy and Clinical Immunology
2026 - Acute Localized Exanthematous Pustulosis After Face and Neck Rhytidectomy: A Case of Locus Minoris Resistentiae
Plastic & Reconstructive Surgery Global Open
2025 - Nasal allergen challenge (NAC): Practical aspects and applications from an EU/US perspective—a Work Group Report of the AAAAI Rhinitis, Rhinosinusitis and Ocular Allergy Committee
Journal of Allergy and Clinical Immunology
2023
Similar KOLs
Other experts from the same institution or the same specialty.
Richard Lockey, MD
University of South Florida
Robert Hauser, MD
University of South Florida
Selim Benbadis, MD
University of South Florida
Pedram Hamrah, MD
University of South Florida
David Felson, MD
Boston University
Marc Hochberg, MD
University of Maryland School of Medicine
Philip Mease, MD
Michelle Petri, MD
Johns Hopkins University School of Medicine
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”